Zheshang Securities(SH:601878) Xin Lang Cai Jing·2025-10-24 03:04Group 1 - The core point of the article highlights the decline in the stock price of Shuotai Shen, which fell by 5.01% to 33.75 CNY per share, with a trading volume of 814 million CNY and a turnover rate of 5.20%, resulting in a total market capitalization of 16.125 billion CNY [1] - Shuotai Shen (Beijing) Biopharmaceutical Co., Ltd. is primarily engaged in the research, production, and sales of biological products and some chemical drugs, with its main revenue sources being: 59.17% from injectable mouse nerve growth factor (Sutai Sheng), 33.19% from compound polyethylene glycol electrolyte powder, and 7.63% from other products [1] Group 2 - From the perspective of major fund holdings, Zhejiang Merchants Securities Asset Management has a fund that heavily invests in Shuotai Shen, specifically the Zhejiang Merchants Huijin Quantitative Selected Mixed Fund (006449), which held 143,900 shares in the second quarter, accounting for 5.18% of the fund's net value, making it the second-largest holding [2] - The Zhejiang Merchants Huijin Quantitative Selected Mixed Fund (006449) has a current scale of 1.04 billion CNY and has achieved a return of 62.7% this year, ranking 329 out of 8,154 in its category, with a one-year return of 42.33%, ranking 1,111 out of 8,025 [2]